Home/Kernal Biologics/Burak Yilmaz

BY

Burak Yilmaz

President & Cofounder

Kernal Biologics

Therapeutic Areas

Oncology Autoimmune Diseases

Kernal Biologics Pipeline

Drug	Indication	Phase
In vivo CAR-T	Bladder cancer, Merkel cell carcinoma, cutaneous squamous cell carcinoma, head and neck cancer	Preclinical

Leadership Team at Kernal Biologics

Chief Executive Officer & Cofounder

SVP, Head of R&D Therapeutics

Head of Platform & Cofounder

Stephen DiPalma

Chief Financial Officer

View full Kernal Biologics profile